rct
    2011
    High Quality

    Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults

    Waller PA, Gopal PK

    Published in Scandinavian Journal of Gastroenterology

    Methodology

    Randomized double-blind placebo-controlled dose-response trial of B. lactis HN019 in adults with functional GI symptoms.

    Key Findings

    Both doses shortened whole gut transit time versus placebo and reduced functional GI symptom scores.

    Conclusions

    B. lactis HN019 accelerates gut transit in a dose-related manner.

    Limitations

    Short duration; industry funded; symptom outcomes self-reported.

    Supplements Studied

    Probiotics
    Probiotic

    Bifidobacterium lactis HN019 shortened whole gut transit time in a dose-related manner

    Outcomes Measured

    Intestinal Motility

    Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults

    Study Details

    Year:2011
    Sample Size:100
    Duration:2 weeks
    Quality Score:7/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.